In a new perspective piece, a physician recalls lessons learned from treating patients affected by the 2002 outbreak of Exophiala (Wangiella) dermatitidis meningitis or arthritis related to contaminated, injectable coticosteroids prepared from a compounding pharmacy.<img src="http://feeds.feedburner.com/~r/sciencedaily/~4/wf5vmQecdL0" height="1" width="1"/>
